Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

盘前交易 08-12 05:33:34 EDT

171.81

-2.46

-1.41%

盘前173.00

+1.19+0.69%

05:17 EDT

最高179.85	最低171.06	成交量334.04万
今开174.44	昨收174.27	日振幅5.04%
总市值672.12亿	流通市值607.32亿	总股本3.91亿
成交额5.85亿	换手率0.94%	流通股本3.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

Data provider: Ningxia XSRK Technology Limited

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":171.81,"timestamp":1660248000000,"preClose":174.27,"halted":0,"volume":3340426,"hourTrading":{"tag":"盘前","latestPrice":173,"preClose":171.81,"latestTime":"05:17 EDT","volume":104,"amount":17999.62944,"timestamp":1660295823315},"delay":0,"floatShares":353485052,"shares":391199544,"eps":32.871437,"marketStatus":"盘前交易","marketStatusCode":1,"change":-2.46,"latestTime":"08-12 05:33:34 EDT","open":174.435,"high":179.85,"low":171.06,"amount":584699949.5920401,"amplitude":0.050439,"askPrice":173,"askSize":47,"bidPrice":172.8,"bidSize":20,"shortable":3,"etf":0,"ttmEps":32.871437,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1660311000000},"adr":0,"listingDate":1544158800000,"adjPreClose":171.81,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":173,"preClose":171.81,"latestTime":"05:17 EDT","volume":104,"amount":17999.62944,"timestamp":1660295823315},"postHourTrading":{"tag":"盘后","latestPrice":171.9,"preClose":171.81,"latestTime":"19:59 EDT","volume":48043,"amount":8258370.7129,"timestamp":1660262373339},"volumeRatio":0.667706587363608},"requestUrl":"/m/hq/s/MRNA","defaultTab":"news","newsList":[{"id":"2258269822","title":"据日本共同社：Moderna寻求日本批准使用针对奥密克戎变异株的疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2258269822","media":"汇通网","top":-1,"share":"https://www.laohu8.com/m/news/2258269822?lang=zh_CN&edition=full","pubTime":"2022-08-10 10:54","pubTimestamp":1660100058,"startTime":"0","endTime":"0","summary":"据日本共同社：Moderna寻求日本批准使用针对奥密克戎变异株的疫苗","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208101054268214810d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208101054268214810d&s=b","is_publish_highlight":false},{"id":"2256292854","title":"MODERNA涨近16%，PAYPAL涨超9%！标普500ETF(513500)飘红","url":"https://stock-news.laohu8.com/highlight/detail?id=2256292854","media":"资本邦","top":-1,"share":"https://www.laohu8.com/m/news/2256292854?lang=zh_CN&edition=full","pubTime":"2022-08-04 13:55","pubTimestamp":1659592538,"startTime":"0","endTime":"0","summary":"午后，标普500ETF 涨超1%，成交额超1.6亿。成分股中，MODERNA涨近16%，贝宝涨超9%，西维斯健康、罗斯百货、脸书均表现强劲，涨超5%。美股市场本周公布了至少210亿美元的新股票回购计划，其中PayPal贝宝牵头，授权了一项150亿美元的新回购计划，与对冲基金Elliott合作，以扭转股价的颓势。Moderna、爱彼迎和万豪酒店也在过去三天增加或公布了新计划。此外，标普500指数成分股中仍有50多家将于本周公布业绩，这意味着该回购公告总数或将继续上升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080413554283d54663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080413554283d54663&s=b","is_publish_highlight":false},{"id":"2256955399","title":"莫德纳新冠疫苗业务依旧强劲，股价盘中大涨逾15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2256955399","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2256955399?lang=zh_CN&edition=full","pubTime":"2022-08-04 00:23","pubTimestamp":1659543818,"startTime":"0","endTime":"0","summary":"莫德纳是最新一家公布季度营收实现增长的疫苗制造公司，此前辉瑞公司也公布了类似的利好数据。","market":"hk","thumbnail":"https://static.tigerbbs.com/dff8fd9af6618f15123dce8663526a4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/dff8fd9af6618f15123dce8663526a4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"https://m.cls.cn/depth/1090013","is_publish_highlight":true},{"id":"1175602340","title":"Moderna大涨16%，Q2业绩超预期并计划回购30亿美元股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1175602340","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1175602340?lang=zh_CN&edition=full","pubTime":"2022-08-03 23:11","pubTimestamp":1659539477,"startTime":"0","endTime":"0","summary":"预计第四季度疫苗销售额好于第三季度。","market":"us","thumbnail":"https://static.tigerbbs.com/9c483ffd9e343907d899477d170b17d1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9c483ffd9e343907d899477d170b17d1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2256657849","title":"Moderna(MRNA)Q2营收同比增9% 非GAAP每股收益超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2256657849","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2256657849?lang=zh_CN&edition=full","pubTime":"2022-08-03 20:39","pubTimestamp":1659530350,"startTime":"0","endTime":"0","summary":"财报显示，Moderna二季度营收47.49亿美元，同比增长9%，较市场预期高出8亿美元;净利润为21.97亿美元，同比下降21%;摊薄后每股收益为5.24美元，上年同期为6.46美元。此外，Moderna宣布新的30亿美元股份回购计划。展望未来，Moderna预计，由于更新的新冠疫苗获得批准的时间以及新产品的相关生产提速，今年下半年第四季度的销量将高于第三季度。Moderna预计全年研发与销售、一般和行政费用为40亿美元。截至发稿，Moderna盘前涨4.47%，报168美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/765916.html","is_publish_highlight":false},{"id":"2256500399","title":"Moderna(MRNA)盘前涨3% Q2业绩超预期 宣布新的30亿美元股份回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2256500399","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2256500399?lang=zh_CN&edition=full","pubTime":"2022-08-03 19:50","pubTimestamp":1659527402,"startTime":"0","endTime":"0","summary":"周三美股盘前，Moderna(MRNA)公布了2022年第二季度财务业绩。数据显示，该公司Q2营收47.5亿美元，预期40.65亿美元；净利润22亿美元，预期19.29亿美元；每股收益5.24美元。第二季度研发支出7.1亿美元，预估6.46亿美元。该公司预计第四季度疫苗销售额好于第三季度。此外，Moderna宣布新的30亿美元股份回购计划。截止发稿，Moderna盘前涨3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=1e58c852c06d8f11712e6a741aaa8ab3","is_publish_highlight":false},{"id":"2256960572","title":"Moderna(MRNA.US)CEO Bancel:针对BA.1和BA.4/5的新冠疫苗已经投入生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2256960572","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2256960572?lang=zh_CN&edition=full","pubTime":"2022-08-03 19:48","pubTimestamp":1659527290,"startTime":"0","endTime":"0","summary":"【Moderna(MRNA.US)CEO Bancel：针对BA.1和BA.4/5的新冠疫苗已经投入生产】Moderna(MRNA.US)CEO Bancel：针对BA.1和BA.4/5的新冠疫苗已经投入生产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080319513082117dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080319513082117dd3&s=b","is_publish_highlight":false},{"id":"2256967848","title":"Moderna(MRNA.US):第二季度研发支出7.1亿美元,预估6.46亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2256967848","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2256967848?lang=zh_CN&edition=full","pubTime":"2022-08-03 19:27","pubTimestamp":1659526039,"startTime":"0","endTime":"0","summary":"【Moderna(MRNA.US)：第二季度研发支出7.1亿美元，预估6.46亿美元】Moderna(MRNA.US)：第二季度研发支出7.1亿美元，预估6.46亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080319304882117b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080319304882117b97&s=b","is_publish_highlight":false},{"id":"2256960653","title":"Moderna(MRNA.US):预计第四季度疫苗销售额好于第三季度","url":"https://stock-news.laohu8.com/highlight/detail?id=2256960653","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2256960653?lang=zh_CN&edition=full","pubTime":"2022-08-03 19:27","pubTimestamp":1659526039,"startTime":"0","endTime":"0","summary":"【Moderna(MRNA.US)：预计第四季度疫苗销售额好于第三季度】Moderna(MRNA.US)：预计第四季度疫苗销售额好于第三季度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080319304183d51250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080319304183d51250&s=b","is_publish_highlight":false},{"id":"2256599785","title":"Moderna第二季度营收47.49亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2256599785","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2256599785?lang=zh_CN&edition=full","pubTime":"2022-08-03 19:12","pubTimestamp":1659525123,"startTime":"0","endTime":"0","summary":"Moderna第二季度营收47.49亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208031912138460c6ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208031912138460c6ab&s=b","is_publish_highlight":false},{"id":"2256997858","title":"Moderna二季度营收47.49亿美元，宣布30亿美元回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2256997858","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/2256997858?lang=zh_CN&edition=full","pubTime":"2022-08-03 19:12","pubTimestamp":1659525120,"startTime":"0","endTime":"0","summary":"Moderna2022年Q2 营收（亿美元）：47.49，预期：40.65，前值：43.54。Q2 净利润（亿美元）：21.97，预期：19.29，前值：27.80。Q2 EPS：$5.24，预期：$4.57，前值：$6.46。Moderna预计第四季度疫苗销售额好于第三季度。Moderna宣布新的30亿美元股份回购计划。财报公布后，Moderna盘前涨近3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208031923548460c734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208031923548460c734&s=b","is_publish_highlight":false},{"id":"2256954636","title":"SVB Securities:将Moderna(MRNA.US)目标价从70美元上调至77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2256954636","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2256954636?lang=zh_CN&edition=full","pubTime":"2022-08-01 12:39","pubTimestamp":1659328758,"startTime":"0","endTime":"0","summary":"【SVB Securities：将Moderna(MRNA.US)目标价从70美元上调至77美元】SVB Securities：将Moderna(MRNA.US)目标价从70美元上调至77美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208011241078210a0ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208011241078210a0ab&s=b","is_publish_highlight":false},{"id":"2255511775","title":"Moderna(MRNA.O)盘前拉升约2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2255511775","media":"媒体滚动","top":-1,"share":"https://www.laohu8.com/m/news/2255511775?lang=zh_CN&edition=full","pubTime":"2022-07-29 20:06","pubTimestamp":1659096368,"startTime":"0","endTime":"0","summary":"Moderna(MRNA.O)盘前拉升约2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-07-29/doc-imizmscv4065732.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-07-29/doc-imizmscv4065732.shtml","is_publish_highlight":false},{"id":"1181567377","title":"美国抗疫概念股走低，诺瓦瓦克斯医药跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181567377","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1181567377?lang=zh_CN&edition=full","pubTime":"2022-07-28 22:00","pubTimestamp":1659016837,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"1115476075","title":"新冠疫苗竞赛进行到哪儿了？","url":"https://stock-news.laohu8.com/highlight/detail?id=1115476075","media":"锦缎","top":-1,"share":"https://www.laohu8.com/m/news/1115476075?lang=zh_CN&edition=full","pubTime":"2022-07-27 10:40","pubTimestamp":1658889601,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/d1e71fbaf4ee745a42a5b0c0553fcfa6","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d1e71fbaf4ee745a42a5b0c0553fcfa6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2254898800","title":"生物创投的骗局大抵相通，而我们只是不想做韭菜","url":"https://stock-news.laohu8.com/highlight/detail?id=2254898800","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2254898800?lang=zh_CN&edition=full","pubTime":"2022-07-26 09:14","pubTimestamp":1658798054,"startTime":"0","endTime":"0","summary":"几乎是复刻了Theranos的骗局","market":"sh","thumbnail":"https://img.huxiucdn.com/article/cover/202207/26/084347301130.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202207/26/084347301130.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.huxiu.com/article/618186.html","is_publish_highlight":false},{"id":"1182557063","title":"机构：辉瑞和Moderna的二季度新冠疫苗销售额均将跌超60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182557063","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1182557063?lang=zh_CN&edition=full","pubTime":"2022-07-25 19:37","pubTimestamp":1658749047,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2254007809","title":"Airfinity：辉瑞(PFE.US)、Moderna(MRNA.US)Q2新冠疫苗营收料将环比跌六成","url":"https://stock-news.laohu8.com/highlight/detail?id=2254007809","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2254007809?lang=zh_CN&edition=full","pubTime":"2022-07-25 11:28","pubTimestamp":1658719705,"startTime":"0","endTime":"0","summary":"在最新的预测中，Airfinity预计辉瑞/BioNTech新冠疫苗将在本季度产生48亿美元的收入，这意味着与第一季度的132亿美元收入相比，环比下降63%。与此同时，Airfinity预计阿斯利康将从2022年第二季度新冠疫苗销售额将为3.86亿美元，环比下降66%。Airfinity指出，基于跟踪全球疫苗交付数据的预测反映了世界各地对新冠疫苗的需求下降。根据Airfinity的数据，辉瑞/BioNTech和Moderna的全年疫苗销售预计将在2022年反弹，占市场份额高达21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/760722.html","is_publish_highlight":false},{"id":"2253047921","title":"概念掘金 | WHO宣布猴痘构成“全球突发公共卫生事件”，全球感染者超 1.6 万例","url":"https://stock-news.laohu8.com/highlight/detail?id=2253047921","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2253047921?lang=zh_CN&edition=full","pubTime":"2022-07-24 11:28","pubTimestamp":1658633332,"startTime":"0","endTime":"0","summary":"国际关注的突发公共卫生事件","market":"us","thumbnail":"https://img3.gelonghui.com/9f442-96fd22d2-21e7-4862-a4ee-96267c63b7d6.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9f442-96fd22d2-21e7-4862-a4ee-96267c63b7d6.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.gelonghui.com/p/541200","is_publish_highlight":false},{"id":"2253056851","title":"欧洲药品管理局(EMA)：开始评估Moderna新冠疫苗Spikevax改良版的授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2253056851","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2253056851?lang=zh_CN&edition=full","pubTime":"2022-07-22 22:10","pubTimestamp":1658499048,"startTime":"0","endTime":"0","summary":"欧洲药品管理局(EMA)：开始评估Moderna新冠疫苗Spikevax改良版的授权申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220722221104845e92ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220722221104845e92ae&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1152},{"period":"1month","weight":-0.0083},{"period":"3month","weight":0.2458},{"period":"6month","weight":0.065},{"period":"1year","weight":-0.5541},{"period":"ytd","weight":-0.3235}],"websiteUrl":"http://www.modernatx.com","compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.1028},{"period":"3month","weight":0.0455},{"period":"6month","weight":-0.0465},{"period":"1year","weight":-0.0536},{"period":"ytd","weight":-0.1157}],"name":"Moderna, Inc.","description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。他们正在创建一种新的基于信使RNA或mRNA的转化药物，以改善患者的生活。从一开始，他们设计了他们的策略和操作，以在很长的时间范围内实现mRNA在各种人类疾病中的全部潜在价值和影响。该公司建立并持续投资一个以推进mRNA药物的技术前沿为目的的平台，以推进mRNA药物的研发。他们制定并继续对可扩展的基础设施和能力进行前瞻性投资，以寻求能够反映mRNA机会广度的潜在药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.114971},{"month":2,"riseRate":0.5,"avgChangeRate":0.10671},{"month":3,"riseRate":0.5,"avgChangeRate":0.005709},{"month":4,"riseRate":0.75,"avgChangeRate":0.240127},{"month":5,"riseRate":0.75,"avgChangeRate":0.062854},{"month":6,"riseRate":0.5,"avgChangeRate":0.000405},{"month":7,"riseRate":0.75,"avgChangeRate":0.175583},{"month":8,"riseRate":0.75,"avgChangeRate":0.047205},{"month":9,"riseRate":1,"avgChangeRate":0.041358},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.032416},{"month":11,"riseRate":1,"avgChangeRate":0.500086},{"month":12,"riseRate":0,"avgChangeRate":-0.211555}],"exchange":"NASDAQ","nameEN":"Moderna, Inc.","compareStock":{"symbol":"SPY","name":"标普500ETF"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.8.2","shortVersion":"4.8.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情"}}